Literature DB >> 22293474

Three-dimensional solution structure of bottromycin A2: a potent antibiotic active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci.

Hiroaki Gouda1, Yutaka Kobayashi, Takeshi Yamada, Tetsuya Ideguchi, Akihiro Sugawara, Tomoyasu Hirose, Satoshi Omura, Toshiaki Sunazuka, Shuichi Hirono.   

Abstract

The three-dimensional (3D) structure of bottromycin A(2), a natural anti-methicillin-resistant Staphylococcus aureus (MRSA) and anti-vancomycin-resistant Enterococci (VRE) agent consisting of seven amino acids, has been investigated through NMR spectroscopy. On the basis of 57 experimental constraints, a total of 34 converged structures were obtained. The average pairwise atomic root mean square difference is 0.74±0.59 Å for all heavy atoms. The resulting structure indicates an interesting feature in that the three C-terminal residues of bottromycin A(2) fold back on the 12-membered cyclic skeleton made by the four N-terminal residues. Thus, MePro(2) and Thia-β-Ala-OMe(7), modification of which significantly affects the antibacterial activities of bottromycin A(2), are located on one side of its 3D structure. These distinct structural features might be important for the binding of bottromycin A(2) with the bacterial ribosome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22293474     DOI: 10.1248/cpb.60.169

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Structure and biosynthesis of the antibiotic bottromycin D.

Authors:  Yanpeng Hou; Ma Diarey B Tianero; Jason C Kwan; Thomas P Wyche; Cole R Michel; Gregory A Ellis; Emmanuel Vazquez-Rivera; Doug R Braun; Warren E Rose; Eric W Schmidt; Tim S Bugni
Journal:  Org Lett       Date:  2012-09-17       Impact factor: 6.005

2.  Synthetic studies towards bottromycin.

Authors:  Stefanie Ackermann; Hans-Georg Lerchen; Dieter Häbich; Angelika Ullrich; Uli Kazmaier
Journal:  Beilstein J Org Chem       Date:  2012-10-01       Impact factor: 2.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.